Effect of Proton Pump Inhibitors on Gastric Juice Volume, Gastric pH and Gastric Intramucosal pH in Critically Ill Patients A Randomized, Double-Blind, Placebo-Controlled Study

被引:21
|
作者
Gursoy, Olcay [1 ]
Memis, Dilek [1 ]
Sut, Necdet [2 ]
机构
[1] Trakya Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-22030 Edirne, Turkey
[2] Trakya Univ, Fac Med, Dept Biostat, TR-22030 Edirne, Turkey
关键词
D O I
10.2165/0044011-200828120-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: This study aimed to determine the effect of administration of a single-dose proton pump inhibitor (PPI) on gastric intramucosal pH (pHi), gastric juice volume and gastric pH in critically ill patients. Methods: This prospective, randomized, double-blind, placebo-controlled study included 75 patients who were divided into five groups that received the following treatment: group C (n = 15), saline 100 mL; group 0 (n = 15), omeprazole 20 mg; group P (n = 15), pantoprazole 40 mg; group E (n = 15), esomeprazole 20 mg; and group R (n = 15), rabeprazole 20 mg. All treatments were administered nasogastrically in 100 mL of physiological saline. Measurements of gastric pHi, gastric juice volume and gastric pH were obtained immediately before and 2, 4 and 6 hours after administration of treatments. In addition, gastric content was aspirated and its volume was recorded. Results: Initial gastric pHi, gastric juice volume and gastric pH values were not statistically significantly different among the groups (p > 0.05). No statistically significant difference in gastric pHi was seen among the groups before or 2, 4 or 6 hours after saline or PPI administration. At hours 2, 4 and 6, gastric pH in the pantoprazole, esomeprazole and rabeprazole groups increased significantly, whereas gastric juice volume decreased significantly, compared with the omeprazole and placebo groups (p < 0.001). No statistically significant differences were seen between the pantoprazole, esomeprazole and rabeprazole groups. Conclusion: This is the first study to show that single-dose pantoprazole, esomeprazole and rabeprazole are associated with greater gastric pH increase and greater gastric juice volume decrease than omeprazole in critically ill patients. Our study also suggests that PPIs do not affect gastric pHi measurements in critically ill patients and can be administered during pH monitoring.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 50 条
  • [21] Gastric intramucosal Pco2, and pH variability in ventilated critically ill patients
    Huang, CC
    Tsai, YH
    Lin, MC
    Tsao, TCY
    Hsu, KH
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (01) : 88 - 95
  • [22] Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress
    Lenz, Kurt
    Buder, Robert
    Firlinger, Fritz
    Lohr, Gerald
    Voglmayr, Martin
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (1-2) : 51 - 56
  • [23] Cisapride suppositories promote gastric emptying in patients with delayed gastric emptying. A double-blind, placebo-controlled study
    Brummer, RJM
    Schoenmakers, EAJM
    Heidendal, GAK
    Engels, LGJB
    vanDeursen, CTBM
    Stockbrugger, RW
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A641 - A641
  • [24] Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: A Randomized, Double-Blind, Placebo-Controlled Study
    Muscedere, John
    Maslove, David M.
    Boyd, J. Gordon
    O'Callaghan, Nicole
    Sibley, Stephanie
    Reynolds, Steven
    Albert, Martin
    Hall, Richard
    Jiang, Xuran
    Day, Andrew G.
    Jones, Gwyneth
    Lamontagne, Francois
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (09) : 1450 - 1456
  • [25] Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients
    Memis, D.
    Hekimoglu, S.
    Vatan, I.
    Yandim, T.
    Yuksel, M.
    Sut, N.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2007, 98 (04) : 550 - 552
  • [26] COMPARISON OF GASTRIC INTRAMUCOSAL PH WITH MEASURES OF OXYGEN-TRANSPORT AND CONSUMPTION IN CRITICALLY ILL PATIENTS
    GUTIERREZ, G
    BISMAR, H
    DANTZKER, DR
    SILVA, N
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (04) : 451 - 457
  • [27] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial
    Alberda, Cathy
    Gramlich, Leah
    Meddings, Jon
    Field, Catherine
    McCargar, Linda
    Kutsogiannis, Demetrios
    Fedorak, Richard
    Madsen, Karen
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03): : 816 - 823
  • [28] Does nimesulide induce gastric mucosal damage?: "A double-blind randomized placebo-controlled trial"
    Kapicioglu, S
    Baki, AH
    Sari, M
    Özdemir, F
    Kavgaci, H
    [J]. HEPATO-GASTROENTEROLOGY, 2000, 47 (34) : 1183 - 1185
  • [29] A Single-Center, Placebo-Controlled, Double-Blind Study to Evaluate the Effects of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation, and Distal Gastric Function in Healthy Volunteers
    Nelson, Alfred D.
    Camilleri, Michael
    Acosta, Andres
    Busciglio, Irene
    Nord, Sara Linker
    Boldingh, Amy
    Rhoten, Deborah
    Ryks, Michael
    Burton, Duane
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S721 - S722
  • [30] Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial
    Sanaie, Sarvin
    Ebrahimi-Mameghani, Mehrangiz
    Hamishehkar, Hadi
    Mojtahedzadeh, Mojtaba
    Mahmoodpoor, Ata
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (09): : 827 - 833